Adaptive Biotechnologies
ADPT
ADPT
226 hedge funds and large institutions have $931M invested in Adaptive Biotechnologies in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 82 increasing their positions, 59 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.69% less ownership
Funds ownership: 94.37% → 91.68% (-2.7%)
14% less capital invested
Capital invested by funds: $1.08B → $931M (-$152M)
Holders
226
Holding in Top 10
2
Calls
$1.23M
Puts
$522K
Top Buyers
| 1 | +$7.82M | |
| 2 | +$4.03M | |
| 3 | +$4.02M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.01M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.56M |
Top Sellers
| 1 | -$73.3M | |
| 2 | -$5M | |
| 3 | -$2.1M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$1.85M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.81M |